MetaCap

Xenetic Biosciences Earnings

NASDAQ: XBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.40-0.14 (-9.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Xenetic Biosciences earnings summary

In its most recent report on Nov 12, 2026 (Sep/2026), XBIO posted EPS of $-0.72.

Summary generated from market data by MetaCap's automated system. Methodology

XBIO earnings history

Xenetic Biosciences reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 12, 2026—$-0.72—-15.7%
Nov 11, 2026—$-0.33—-15.7%
Aug 6, 2026—$-0.41——
May 12, 2026—$-0.20——
Mar 12, 2026—$-0.21——
Nov 12, 2025—$-0.33——
Aug 12, 2025—$-0.45——
May 13, 2025—$-0.59——
Mar 18, 2025—$-0.68——
Nov 12, 2024—$-0.28——
Aug 13, 2024—$-0.83——
May 9, 2024—$-0.78——
Mar 21, 2024—$-0.77——
Nov 9, 2023—$-0.69——
Aug 10, 2023—$-0.69——
May 11, 2023—$-0.56——

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related